196 related articles for article (PubMed ID: 18769623)
1. Role of N-terminal amino acids in the potency of anthrax lethal factor.
Gupta PK; Moayeri M; Crown D; Fattah RJ; Leppla SH
PLoS One; 2008 Sep; 3(9):e3130. PubMed ID: 18769623
[TBL] [Abstract][Full Text] [Related]
2. Anthrax toxin uptake by primary immune cells as determined with a lethal factor-beta-lactamase fusion protein.
Hu H; Leppla SH
PLoS One; 2009 Nov; 4(11):e7946. PubMed ID: 19956758
[TBL] [Abstract][Full Text] [Related]
3. Anthrax lethal factor and edema factor act on conserved targets in Drosophila.
Guichard A; Park JM; Cruz-Moreno B; Karin M; Bier E
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3244-9. PubMed ID: 16455799
[TBL] [Abstract][Full Text] [Related]
4. Chemical dissection of protein translocation through the anthrax toxin pore.
Pentelute BL; Sharma O; Collier RJ
Angew Chem Int Ed Engl; 2011 Mar; 50(10):2294-6. PubMed ID: 21351339
[No Abstract] [Full Text] [Related]
5. A semisynthesis platform for investigating structure-function relationships in the N-terminal domain of the anthrax Lethal Factor.
Pentelute BL; Barker AP; Janowiak BE; Kent SB; Collier RJ
ACS Chem Biol; 2010 Apr; 5(4):359-64. PubMed ID: 20180595
[TBL] [Abstract][Full Text] [Related]
6. Anthrax lethal factor inhibitors as potential countermeasure of the infection.
Kumar BV; Malik S; Grandhi P; Dayam R; Sarma JA
Curr Top Med Chem; 2014; 14(17):1977-89. PubMed ID: 25262802
[TBL] [Abstract][Full Text] [Related]
7. Insights into the anthrax lethal factor-substrate interaction and selectivity using docking and molecular dynamics simulations.
Dalkas GA; Papakyriakou A; Vlamis-Gardikas A; Spyroulias GA
Protein Sci; 2009 Aug; 18(8):1774-85. PubMed ID: 19585464
[TBL] [Abstract][Full Text] [Related]
8. Involvement of domain II in toxicity of anthrax lethal factor.
Liang X; Young JJ; Boone SA; Waugh DS; Duesbery NS
J Biol Chem; 2004 Dec; 279(50):52473-8. PubMed ID: 15465830
[TBL] [Abstract][Full Text] [Related]
9. Cross-linked forms of the isolated N-terminal domain of the lethal factor are potent inhibitors of anthrax toxin.
Juris SJ; Melnyk RA; Bolcome RE; Chan J; Collier RJ
Infect Immun; 2007 Oct; 75(10):5052-8. PubMed ID: 17635861
[TBL] [Abstract][Full Text] [Related]
10. Anthrax lethal factor cleaves regulatory subunits of phosphoinositide-3 kinase to contribute to toxin lethality.
Mendenhall MA; Liu S; Portley MK; O'Mard D; Fattah R; Szabo R; Bugge TH; Khillan JS; Leppla SH; Moayeri M
Nat Microbiol; 2020 Dec; 5(12):1464-1471. PubMed ID: 32895527
[TBL] [Abstract][Full Text] [Related]
11. The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity.
Tonello F; Montecucco C
Mol Aspects Med; 2009 Dec; 30(6):431-8. PubMed ID: 19665472
[TBL] [Abstract][Full Text] [Related]
12. Characterization of membrane translocation by anthrax protective antigen.
Wesche J; Elliott JL; Falnes PO; Olsnes S; Collier RJ
Biochemistry; 1998 Nov; 37(45):15737-46. PubMed ID: 9843379
[TBL] [Abstract][Full Text] [Related]
13. Role of toxin functional domains in anthrax pathogenesis.
Brossier F; Weber-Levy M; Mock M; Sirard JC
Infect Immun; 2000 Apr; 68(4):1781-6. PubMed ID: 10722564
[TBL] [Abstract][Full Text] [Related]
14. LRP5 and LRP6 are not required for protective antigen-mediated internalization or lethality of anthrax lethal toxin.
Young JJ; Bromberg-White JL; Zylstra C; Church JT; Boguslawski E; Resau JH; Williams BO; Duesbery NS
PLoS Pathog; 2007 Mar; 3(3):e27. PubMed ID: 17335347
[TBL] [Abstract][Full Text] [Related]
15. Structural determinants for the binding of anthrax lethal factor to oligomeric protective antigen.
Melnyk RA; Hewitt KM; Lacy DB; Lin HC; Gessner CR; Li S; Woods VL; Collier RJ
J Biol Chem; 2006 Jan; 281(3):1630-5. PubMed ID: 16293620
[TBL] [Abstract][Full Text] [Related]
16. Site directed mutagenesis of histidine residues in anthrax toxin lethal factor binding domain reduces toxicity.
Arora N
Mol Cell Biochem; 1997 Dec; 177(1-2):7-14. PubMed ID: 9450639
[TBL] [Abstract][Full Text] [Related]
17. Computational insights into the interaction of the anthrax lethal factor with the N-terminal region of its substrates.
Joshi M; Ebalunode JO; Briggs JM
Proteins; 2009 May; 75(2):323-35. PubMed ID: 18831046
[TBL] [Abstract][Full Text] [Related]
18. Blocking anthrax lethal toxin at the protective antigen channel by using structure-inspired drug design.
Karginov VA; Nestorovich EM; Moayeri M; Leppla SH; Bezrukov SM
Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15075-80. PubMed ID: 16214885
[TBL] [Abstract][Full Text] [Related]
19. Residue histidine 669 is essential for the catalytic activity of Bacillus anthracis lethal factor.
Cao S; Guo A; Wu G; Liu Z; Chen W; Feng C; Zhang CC; Chen H
J Bacteriol; 2010 Nov; 192(21):5799-805. PubMed ID: 20833809
[TBL] [Abstract][Full Text] [Related]
20. Purification and biophysical characterization of the core protease domain of anthrax lethal factor.
Gkazonis PV; Dalkas GA; Chasapis CT; Vlamis-Gardikas A; Bentrop D; Spyroulias GA
Biochem Biophys Res Commun; 2010 Jun; 396(3):643-7. PubMed ID: 20438702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
